156 related articles for article (PubMed ID: 36891719)
21. [Antiviral treatment for hepatitis C among injecting drug users in the era of direct-acting antiviral agents].
Pan L; Pang L
Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):893-896. PubMed ID: 33105938
[TBL] [Abstract][Full Text] [Related]
22. [Research progress of hepatitis C in 2018].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):6-9. PubMed ID: 30685916
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.
Lazarus JV; Picchio CA; Guy D; Aleman S; James C; Nava FA; Øvrehus A; Turnes J; Ward JW; Ustianowski A
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101564. PubMed ID: 33740477
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C: Is eradication possible?
Lombardi A; Mondelli MU;
Liver Int; 2019 Mar; 39(3):416-426. PubMed ID: 30472772
[TBL] [Abstract][Full Text] [Related]
25. [Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)].
You H; Sun YM; Zhang MY; Nan YM; Xu XY; Li TS; Wang GQ; Hou JL; Duan ZP; Wei L; Wang FS; Jia JD; Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):385-388. PubMed ID: 37248977
[TBL] [Abstract][Full Text] [Related]
26. [Expert consensus on antiviral therapy for HBV/HCV-related hepatocellular carcinoma: a 2021 update].
Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):948-966. PubMed ID: 34814389
[TBL] [Abstract][Full Text] [Related]
27. The Elimination of Hepatitis C as a Public Health Threat.
Hellard M; Schroeder SE; Pedrana A; Doyle J; Aitken C
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31712223
[TBL] [Abstract][Full Text] [Related]
28. [Chronic hepatitis C: achievement, challenge and strategy to eliminate as a public health threat].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):161-168. PubMed ID: 29804387
[TBL] [Abstract][Full Text] [Related]
29. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
Omata M; Kanda T; Wei L; Yu ML; Chuang WL; Ibrahim A; Lesmana CR; Sollano J; Kumar M; Jindal A; Sharma BC; Hamid SS; Dokmeci AK; Al-Mahtab M; McCaughan GW; Wasim J; Crawford DH; Kao JH; Yokosuka O; Lau GK; Sarin SK
Hepatol Int; 2016 Sep; 10(5):681-701. PubMed ID: 27229718
[TBL] [Abstract][Full Text] [Related]
30. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
Jonas MC; Loftus B; Horberg MA
Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
[TBL] [Abstract][Full Text] [Related]
31. Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C.
Sulkowski M; Cheng WH; Marx S; Sanchez Gonzalez Y; Strezewski J; Reau N
Adv Ther; 2021 Jan; 38(1):423-440. PubMed ID: 33145648
[TBL] [Abstract][Full Text] [Related]
32. Accelerating the elimination of hepatitis C in Kuwait: An expert opinion.
Hasan F; Alfadhli A; Al-Gharabally A; Alkhaldi M; Colombo M; Lazarus JV
World J Gastroenterol; 2020 Aug; 26(30):4415-4427. PubMed ID: 32874054
[TBL] [Abstract][Full Text] [Related]
33. Turkey 2017 Clinical Practice Guidelines on recommendations for screening diagnosing and managing hepatitis C virus.
Idilman R; Baykam N; Kaymakoğlu S; Tabak F; Bahçecioğlu HI; Bektaş A; Bulut C; Günşar F; İnan D; Karaosmanoğlu HK; Karasu Z; Kuşçu F; Mete B; Özbakır Ö; Özdoğan OC; Parlak M; Sırmatel F; Topalak Ö; Ünsal B; Guidelines Study Group VH
Turk J Gastroenterol; 2017 Dec; 28(Suppl 2):90-93. PubMed ID: 29303105
[TBL] [Abstract][Full Text] [Related]
34. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).
Rapoud D; Quillet C; Pham Minh K; Vu Hai V; Nguyen Thanh B; Nham Thi Tuyet T; Tran Thi H; Molès JP; Vallo R; Michel L; Feelemyer J; Weiss L; Lemoine M; Vickerman P; Fraser H; Duong Thi H; Khuat Thi Hai O; Des Jarlais D; Nagot N; Laureillard D;
BMJ Open; 2020 Nov; 10(11):e039234. PubMed ID: 33208326
[TBL] [Abstract][Full Text] [Related]
35. The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.
Maticic M; Pirnat Z; Leicht A; Zimmermann R; Windelinck T; Jauffret-Roustide M; Duffell E; Tammi T; Schatz E
Harm Reduct J; 2020 Nov; 17(1):89. PubMed ID: 33213481
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis, Management And Prevention Of Hepatitis C In Pakistan 2017.
Umar M; Khaar HT; Akhter TS; Aslam F; Ahmad SI; Asghar RM; Khurram M; Hussain T; Salamat A; Khan AA; Fazal-E-Hadi ; Minhas ZM; Shah HA; Farooqui J; Naqvi AA; Mohsin A; Waseem-Ud-Din ; Bhutta SI; Hasnain Syed SU; Qureshi S; Adam T; Uddin M; Tayyab GU; Najeeb Ul Haq ; Shoaib A; Ambreen S; Shahzad A; Ikram N; Nisar G; Khan MM; Osama M
J Ayub Med Coll Abbottabad; 2016; 28(4 Suppl 1):S839-S882. PubMed ID: 28782337
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C Virus.
Kaplan DE
Ann Intern Med; 2020 Sep; 173(5):ITC33-ITC48. PubMed ID: 32866406
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.
Ansaldi F; Orsi A; Sticchi L; Bruzzone B; Icardi G
World J Gastroenterol; 2014 Aug; 20(29):9633-52. PubMed ID: 25110404
[TBL] [Abstract][Full Text] [Related]
39. [The guideline of prevention and treatment for hepatitis C: a 2015 update].
; Wei L; ; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):906-23. PubMed ID: 26739465
[No Abstract] [Full Text] [Related]
40. [Treatment and prevention of hepatitis C--progress and challenges. The Danish Society of Hepatology].
Bukh J; Christensen E; Krogsgaard K
Ugeskr Laeger; 2003 Mar; 165(12):1233. PubMed ID: 12701283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
